Lactose (India) Reports Strong Q2 FY24-25 Growth Amid Long-Term Financial Concerns

Lactose (India), a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation adjustment reflecting its current market dynamics. The company has reported positive financial performance for the second quarter of FY24-25, showcasing a notable growth in profit after tax (PAT) and operating cash flow. Specifically, PAT has reached Rs 4.30 crore, marking a significant increase, while operating cash flow has also achieved its highest level at Rs 8.78 crore.
Despite these positive indicators, the evaluation adjustment highlights concerns regarding the company's long-term fundamental strength, particularly its average Return on Capital Employed (ROCE) of 9.81% and a high Debt to EBITDA ratio of 3.61 times, which suggests challenges in servicing debt. The technical trend has shown a sideways movement, indicating a lack of clear price momentum.

Lactose (India) has consistently delivered positive results over the last six quarters and has outperformed the BSE 500 index over various time frames. The stock is currently trading at a discount compared to its historical valuations, with a PEG ratio of 0.1, suggesting an attractive valuation relative to its earnings growth.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.